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vEXECUTIVE SUMMARY
It is estimated that 222 million women in the develop-
ing world have an unmet need for contraception. The 
high level of unmet need is partly due to the limited 
use of contraception by women during the first six to 
12 months postpartum and high discontinuation rates 
with about half of all users abandoning their methods 
six months after adoption. New methods that offer 
greater ease of use, are women-controlled, and do 
not require significant health infrastructure or medical 
provider involvement for service delivery have the po-
tential to increase family planning uptake during the 
postpartum period and reduce discontinuation rates. 
One such method is the progesterone vaginal ring 
(PVR), a user-controlled, mid-acting contraceptive that, 
according to clinical trial data, is safe and effective for 
breastfeeding women.
The Population Council has embarked on a three-
year project to explore the acceptability of the PVR 
among women in sub-saharan Africa and to develop 
a strategic plan for its introduction. Between febru-
ary and May 2012, assessments were undertaken in 
Kenya to map the landscape of family planning pro-
grams and new contraceptive technologies, identify 
national priorities, and assess the level of interest in 
the PVR among stakeholders in order to inform the 
design of appropriate pre-introductory activities. The 
assessments involved: (1) review of Demographic 
and health surveys (Dhs) data; (2) desk review of 
documents, project reports and policy guidelines; 
and (3) key informant interviews with representa-
tives of government, regulatory, and development 
agencies; social marketing organizations; research 
institutions; manufacturers/distributors; the commu-
nity; advocacy groups; public/private partnerships; 
and other organizations providing family planning 
services. 
This report presents the findings of the assess-
ments with specific focus on: (1) the country’s 
demographic profile; (2) the health systems, health 
policy, and family planning program context; and (3) 
stakeholder perspectives regarding the PVR. The find-
ings suggest that the introduction of the PVR would fill 
a gap in the family planning needs of breastfeeding 
women in Kenya. In addition, there is strong support 
from stakeholders for future introduction of the PVR. 
Given the health system challenges (staffing and 
infrastructure), there is a need for contraceptives that 
require little training on the part of the provider, do 
not require a sophisticated health infrastructure, are 
long-acting and thus do not require monthly visits to a 
health center, are user-friendly and woman-controlled, 
and are safe. The PVR addresses all of these con-
cerns and based on the information documented thus 
far, is likely to be a welcome addition to the existing 
contraceptive method mix in the country.

1INTRODUCTION
while the progress made in recent decades in fertility 
reduction has been impressive, still up to 222 million 
women in the developing world report an unmet need 
for contraception (singh and Darroch 2012). Part of the 
challenge in addressing current levels of unmet need is 
the limited use of contraception by women during the 
first six to 12 months postpartum and the discontinua-
tion rates with about half of all users abandoning their 
methods six months after adoption. Both issues lead to 
limited success in effective birth spacing, which then 
can negatively impact maternal and infant health. New 
methods are needed that offer greater ease of use, are 
women-controlled and do not require significant health 
infrastructure or medical provider involvement for 
service delivery. One such method is the progesterone 
vaginal ring (PVR), a user-controlled, mid-acting contra-
ceptive that, according to clinical trial data, is safe and 
effective for breastfeeding women. 
The Population Council has embarked on a three-
year project to explore the acceptability of the PVR 
among women in sub-saharan Africa and to develop 
a strategic plan for its introduction. from february to 
May 2012 assessments were undertaken in poten-
tial study countries—Kenya, Nigeria, and senegal—to 
map the landscape of family planning programs and 
new contraceptive technologies in an effort to identify 
national priorities and assess the level of interest in the 
PVR among stakeholders and to design appropriate pre-
introductory activities. The Council’s research teams 
in each of these countries employed three approaches 
to develop country-specific reports:  review of Demo-
graphic and health survey (Dhs) data, desk review of 
documents, project reports and policy guidelines, and 
key informant interviews. Interviews were held with 
representatives of key government, regulatory, and 
development agencies; social marketing organizations; 
research institutions; manufacturers/distributors, the 
community; advocacy groups; public/private partner-
ships; and other organizations providing family planning 
services. This report presents the findings from the 
stakeholder mapping exercise in Kenya. It begins by 
describing the country’s demographics and unmet need 
for contraception. It then provides the reproductive 
health and family planning context as well as the con-
traceptive program and policy context before conclud-
ing with the stakeholder support known thus far and a 
discussion of what this could mean moving forward with 
regard to PVR introduction.
DEMOGRAPHIC PROFILE
The population of Kenya more than doubled over a 
period of three decades from 10.9 million people in 
1969 to 28.7 million by 1999 (CBs 1970; CBs 2001). 
In 2009, it was 38.6 million and is projected to reach 
64 million by 2030 (KNBs 2010). In addition, nearly 
two-thirds (63%) of the population is under the age of 
25 years (64% of the men and 63% of the women), 
while 43% is aged below 15 years (44% of the men and 
42% of the women) (CBs 2001). 
The steady increase in the country’s population and 
the huge proportion of young people are partly due to 
previous high fertility rates and initial rapid declines in 
under-five mortality. Kenya had one of the highest fertil-
ity rates (8.1 children per woman) in the world as of 
1978 (CBs 1981). The fertility rate declined by almost 
half over a period of two decades to 4.7 children per 
woman by 1998, one of the most rapid declines ever 
documented (NCPD and CBs 1999). however, between 
1998 and 2008–2009, the fertility rate remained 
largely unchanged at 4.7 and 4.6 children per woman 
by 1998 and 2008-2009 respectively (CBs, MOh, and 
ORC Macro 2004; KNBs and ICf Macro 2010). 
2The country also experienced rapid declines in 
under-five mortality between the early 1960s and early 
1980s from 211 deaths per 1,000 live births by 1962 
to 105 deaths per 1,000 live births by 1989, but this 
progress slowed in the early 1990s (Ikamari 2004). 
Although the under-five mortality rate had declined to 
74 deaths per 1,000 live births by 2008–2009, the 
levels remain unacceptably high. Maternal mortality, on 
the other hand, declined from 590 maternal deaths per 
100,000 live births in 1998 to 414 by 2003 before in-
creasing to 488 by 2008-2009. hIV prevalence among 
adults aged 15–49 years remained fairly unchanged 
over a period of five years at 6.7% in 2003 and 6.3% in 
2008–2009 [CBs, MOh, and ORC Macro 2004; KNBs 
and ICf Macro 2010).
The Kenya government recognizes that sexual and 
reproductive health care, including family planning 
information and services, is a key intervention area 
for improving the health of women, men, and children. 
The country’s demographic patterns (rapid population 
growth, high fertility rates, and high levels of maternal 
and under-five mortality) are therefore likely to put a 
heavy demand on reproductive health services, includ-
ing family planning.
Kenya’s contraceptive prevalence rate (CPR)—the 
percentage of currently married women of reproduc-
tive age (15–49 years) using any method of family 
planning—increased more than five times from 7% in 
1978 to 39% in 1998, which corresponds to the period 
when fertility rates declined by almost half (KNBs 2010; 
CBs 1981). The CPR stalled at 39% between 1998 and 
2003 before increasing to 46% by 2008-2009 CBs 
1981; NCPB, CBs and MI 1999; CBs, MOh, and ORC 
Macro 2004). Over the same period, the proportion of 
currently married women who would like to delay or limit 
childbearing increased from 72% to 76% (Table 1). The 
level of unmet need for family planning—the percentage 
of currently married women who either do not want any 
more children or want to wait two or more years before 
having another child but are not using contraception—
was about 25% (from 24% in 1998 to 26% in 2008–
2009; see Table 1). The indicators in Table 1 show that 
over the years, women on average desire fewer children 
than they actually give birth to. 
while competing health program and funding pri-
orities may have contributed to the lack of significant 
progress in fertility and family planning indicators noted 
in Table 1 (Askew et al. 2009), the Kenya government 
embarked on deliberate and conscious efforts to reposi-
tion family planning in the national development agenda 
described in the next section.
table 1: Kenya feRtility and family Planning indicatoRs
 TOTAL TOTAL WOULD LIKE TO UNMET NEED 
 FERTILITY WANTED DELAY OR LIMIT FOR 
SURVEY YEAR RATE FERTILITY RATE CHILDBEARING CONTRACEPTION
1998 4.7 3.5 72% 24%
2003 4.9 3.6 73% 25%
2008–09 4.6 3.4 76% 26%
sOURCE: Kenya Demographic and health surveys 1998, 2003, 2008–09
 POPULATION: 38.6 million
 PROjECTED  
 POPULATION IN 2030: 64 million
 GROWTH RATE: 2.8%
 TOTAL FERTILITY RATE: 4.6 children per woman
 MATERNAL  
 MORTALITY RATIO: 488/100,000
 INFANT 
 MORTALITY RATE: 74/1,000
 BIRTHS OCCURRING  
 WITHIN 24 MONTHS  
 AFTER PRIOR BIRTH: 23%
 HIV INCIDENCE: 6.3%
demogRaPHic snaPsHot
3HEALTH SYSTEMS  
OVERVIEW
Health Systems 
The major healthcare providers in Kenya, the Ministry 
of Public health and sanitation and the Ministry of 
Medical services, operate over half of all health facili-
ties around the country. These public health facilities 
remain the major source of family planning and repro-
ductive health services. fifty-seven percent of women 
obtain a form of modern contraception from a public 
health facility, with the rest obtaining methods from 
private health facilities (36%) and other sources such 
as mobile clinics, community-based distributors, local 
shops, and friends and family (6%).
The second National health sector strategic Plan 
(NhssP II) of 2005–2010 outlined six levels of health 
service delivery in the country under the Kenya Es-
sential Package for health (KEPh) (Republic of Kenya 
MOh 2005). These include the community (level 1); 
dispensaries and clinics (level 2); health centers, 
maternity and nursing homes (level 3); primary, 
subdistrict, district, and mission hospitals (level 4); 
secondary and provincial hospitals (level 5); and 
tertiary hospitals (Level 6). Table 2 summarizes the 
family planning services delivered at each level as 
well as the available service providers.
family planning services are also provided through 
private pharmacies and social marketing programs. 
According to the National family Planning Guidelines 
for service Providers, private pharmacies should coun-
LEVEL  SERVICE PROVIDERS  FAMILY PLANNING SERVICES
lEVEl 1: 
Community
Community health workers (Chws)• 
Community health extension workers • 
(ChEws)
Community midwives• 
family planning counseling• 
Provision of condoms• 
Referral for other methods• 
lEVEl 2: 
Dispensaries  
and clinics
Nurse/midwife• 
Public health technician• 
ChEws• 
family planning counseling• 
Provision of condoms, pills, injectables• 
Provision of implants and IUCD • 
depending on training
Referral for other methods• 
lEVEl 3:  
health centers, 
maternity and 
nursing homes
Doctor (outreach)• 
Clinical officer• 
Nurse/midwife• 
Public health technician• 
ChEws• 
family planning counseling• 
Provision of condoms, pills, injectables• 
Provision of implants and IUCD • 
depending on training
Provision of bilateral tubal ligation and • 
vasectomy as outreach
Referral for other methods• 
lEVEl 4:  
Primary, 
subdistrict, 
district, and 
mission hospitals
Doctors• 
Clinical officer• 
Nurse/midwife• 
Public health officer or technician• 
family planning counseling• 
Provision of full range of family • 
planning methods
lEVEls 5 and 6:  
secondary, 
provincial, and 
tertiary hospitals
Doctors (including specialists)• 
Clinical officer• 
Nurse/midwife• 
family planning counseling• 
Provision of full range of family • 
planning methods
sOURCE: Division of Reproductive health (DRh)/Ministry of Public health and sanitation (MOPhs). 2010. National Family Planning Guide-
lines for Service Providers. Nairobi: DRh/MOPhs; pp.38–40.; IUCD: Intrauterine contraceptive device
table 2: leVels of family Planning seRVice deliVeRy in Kenya
4sel clients on and provide or sell condoms, pills, inject-
ables, implants, and standard Days Methods (sDM) 
(DRh and MOPhs 2010). In addition, they should refer 
clients for lactational amenorrhea methods (lAM), 
injection, intrauterine contraceptive device (IUCD), 
other fertility-based awareness methods (fAM), and 
sterilization. Social marketing programs are, on the 
other hand, expected to promote, sell, or refer clients 
for most of the family planning methods except fAM 
and sterilization where the guidelines stipulate that 
they should only refer clients (DRh and MOPhs 2010)
FAMILY PLANNING AND 
REPRODUCTIVE HEALTH 
POLICY CONTEXT
Kenya was the first sub-Saharan African country to  
establish a national family planning programme 
(which was regarded as an African success story) 
through the National family Planning Policy (NfPP) 
of 1967. However, it was not until 1984 that the first 
population policy—Population Policy Guidelines—was 
developed. A number of population and health poli-
cies have since been put in place especially since the 
1994 International Conference on Population and 
Development (ICPD).
The National Population Policy for sustainable 
Development was developed in 2000. The Policy 
widened the scope for addressing population issues 
by integrating a domestic Programme of Action of 
the ICPD. It had the objectives of: (1) improving the 
standards of living and the quality of life of the people; 
(2) fully integrating population concerns into the 
development process; (3) motivating and encourag-
ing Kenyans to adhere to responsible parenthood; (4) 
promoting the stability of the family; (5) empowering 
women and eliminating retrogressive socio-cultural 
practices such as female genital mutilation; and  (6) 
integrating the youth, the elderly, and persons with 
disabilities into the mainstream in national develop-
ment (NCPD 2000).
In 2003, the government developed the Adolescent 
Reproductive health and Development Policy with 
one of its key targets being to double the contracep-
tive prevalence rate among adolescents aged 15–19 
and youth aged 20–24 years by 2015 (NCPD and 
DRh). since 2005, the government has embarked on 
deliberate and conscious efforts to reposition family 
planning in the national development agenda. Key 
among these efforts was the development of the first 
National Reproductive health Policy in 2007 that out-
lined family planning as one of the priority reproduc-
tive health components and recognized that the avail-
able family planning methods do not allow for a wide 
method choice (MOH 2007). The policy’s aim was to 
guide planning, standardization, implementation, and 
monitoring and evaluation of reproductive health care 
provided by various stakeholders. The policy allowed 
the government to incorporate and address key issues 
such as security of reproductive health commodities, 
prevention of mother-to-child transmission of hIV, 
emergency obstetric care, adolescent reproductive 
health issues, gender-based violence, reproductive 
health needs of persons with disabilities, and integra-
tion of reproductive and hIV health care (MOh 2007).
In 2008, the government developed a strategy 
to increase the uptake of long-acting or permanent 
methods (lAPMs). One of the areas of focus for the 
strategy was ensuring a wider availability of method 
choices through enhanced commodity security, equip-
ment and supplies (MOPhs/DhR 2008). In 2009, 
the government unveiled a strategy for the period 
2009–2015 to guide the implementation of the 
National Reproductive health Policy. The objectives 
of the strategy with respect to family planning are to 
reduce unmet need, unplanned births, and regional 
and socioeconomic disparities in the CPR (MOPhs 
and MOMs 2009). 
In 2010, the government issued revised National 
family Planning Guidelines for service Providers that 
outlined the recommended practices in the provi-
sion of family planning services in the country (DRh/
MOPhs 2010). The guidelines further addressed 
issues relevant for the provision of family planning 
services including enhancing the functions of com-
munity health workers and community-based distribu-
tors and male involvement. The government also 
convened the National Population Leaders’ Confer-
ence in Nairobi. The conference provided leaders 
from around the country with an opportunity to: (1) 
address critical population issues—including repo-
sitioning family planning – that affect the quality of 
life of Kenyans; and (2) shape clear, succinct, and 
understandable messages about these issues for the 
general population. 
5The government further formulated other devel-
opment policies that have direct bearing on popula-
tion and health issues. for instance, following the 
adoption of the United Nations (UN) Millennium 
Development Goals (MDGs) in 2000, the government 
launched MDG-based planning and budgeting 
in 2004. The MDGs include targets to be achieved 
by 2015 in the areas of eradicating poverty and hun-
ger, achieving universal primary education, promoting 
gender equality, reducing child mortality, improving 
maternal health, combating hIV/AIDs and other 
diseases, reducing environmental degradation, and 
fostering partnerships with international development 
partners (Republic of Kenya 2005). 
Kenya has taken many steps to ensure that repro-
ductive health and family planning are at the center 
of the national agenda by recognizing the need for 
expanding contraceptive choice, setting time-based 
objectives to see improvements in related indicators, 
and repositioning family planning. The policy environ-
ment in Kenya is therefore open to and supportive of 
new-method introduction.
FAMILY PLANNING AND 
REPRODUCTIVE HEALTH  
PROGRAM CONTEXT
Healthcare Utilization Patterns
Estimates from the 2008–2009 Kenya Demographic 
and health survey (KDhs) show that whereas 92% 
of expectant women in the country receive antenatal 
care from skilled providers, only 43% of births occur 
in health facilities while another 44% of births are 
delivered under skilled care (KNBs and ICf Macro 
2010). In addition, only 47% of the mothers report 
receiving a postnatal check-up after the birth (KNBs 
and ICf Macro 2010). however, more than three-
quarters (77%) of the children aged between 12 and 
23 months are fully immunized (KNBS and ICF  
Macro 2010). 
There are wide regional and socioeconomic varia-
tions in the use of reproductive health services in 
the country. for instance, the proportion of women 
delivering in a health facility is more than twice as 
high in the urban compared to rural areas (75% and 
35%, respectively) and more than four times higher 
among women from the richest compared to those 
from the poorest households (81% compared to 18%, 
respectively). It is also more than three times higher 
in Nairobi compared to North Eastern province (89% 
and 17%, respectively). A similar pattern is noted with 
respect to contraceptive use. In particular, the contra-
ceptive prevalence rate (CPR) in urban areas is 53% 
while it is lower in the rural areas (43%). CPR is also 
more than twice as high among women from the rich-
est households compared to those from the poorest 
households (55% and 20%, respectively) and more 
than 16 times higher in Central compared to North 
Eastern province (67% and 4%, respectively). 
Contraceptive Use and Method Mix
The family planning methods available in Kenya are: 
(1) hormonal methods: including combined oral con-
traceptives (COCs); Progestin-only contraceptive pills, 
Progestin-only injectable contraceptives (DMPA, NET-
EN); Progestin-only contraceptive implants (Jadelle, 
Implanon, Zarin, sino-Implant); and dedicated 
emergency hormonal contraceptive pills (Postinor2, 
Pregnon, smart lady, ECee2, Truston2); (2) IUCDs: 
copper-based devices (Copper T380A) and hormone-
releasing Intra-Uterine systems (Mirena lNG-20IUs); 
(3) voluntary surgical contraception for women (tubal 
ligation or female sterilization) and men (vasectomy 
or male sterilization); (4) barrier methods: male and 
female condoms, diaphragms, cervical caps, and 
spermicides; although the use of diaphragms, cervical 
caps and spermicides is negligible; (5) lactational 
amenorrhoea method (lAM): lack of ovulation which 
results from exclusive breastfeeding; and (6) fAMs: 
calendar-based methods such as the standard Days 
Method® (sDM); symptoms-based methods such 
as the. TwoDay Method® (TDM), Cervical Mucus 
or Billings Ovulation Method, Basal Body Tempera-
ture (BBT), and sympto-thermal Method (Cervical 
Mucus+BBT); and withdrawal or coitus interruptus 
method (DRh/MOPhs 2010).
Modern family planning methods are the most 
commonly used contraceptives (by 39% of currently 
married women) compared to traditional methods 
such as rhythm, withdrawal, or folk methods. Over 
the years, injectables have been the most commonly 
used modern of family planning methods followed by 
the pill and female sterilization (Figure 2). The use of 
6injectables almost doubled from 12% in 1998 to 22% in 
2008–09 while the use of pills declined from 9%  
to 7% over the same period (figure 2). The use of fe-
male sterilization, on the other hand, declined from 6% 
in 1998 to 4% in 2003 before slightly increasing to 5% 
in 2008–09. Preference for injectables is also evident 
among married women who are not using contracep-
tives but intend to use in future: slightly more than half 
(52%) prefer injectables, 12% prefer the pill, 8% prefer 
female sterilization, and another 8% prefer implants. 
sino-Implant was the last contraceptive method to 
be introduced in Kenya. Experience from its introduction 
shows that the country of origin/manufacturer is critical 
in influencing people’s perceptions about the product. 
In addition, experiences from the introduction of other 
methods such as emergency contraceptives show that 
products that are user-controlled are quite popular with 
clients as opposed to those that are solely provided by 
healthcare workers. The involvement of government of-
ficials from the outset of product introduction planning 
is also critical as is the need for repeat training and 
technical supervision of service providers during the 
introduction process (Keesbury et al. 2009; shauri and 
Vail 2009). It is also worth noting that the use of and 
attitudes surrounding hormonal contraception in Kenya 
appear to be unchanged in light of the recent inconclu-
sive evidence regarding hormonal contraception and 
the acquisition of hIV (MOPhs 2011). 
since the PVR is a product that is self-inserted into 
the vagina, the use of other vaginal products may serve 
as a proxy for its uptake. Products that are inserted into 
the vagina, such as the diaphragm and menstrual cups, 
have received mixed reactions in Kenya. for instance, 
in a study conducted in Mombasa among female sex 
workers, the diaphragm was found to be an accept-
able method with high user satisfaction (luchters et 
al. 2007). In contrast, in a study of the acceptability of 
the menstrual cup in Nairobi, most participants en-
countered discomfort while some complained that they 
could feel the cup in their vaginas or some pain at the 
first attempt (APHRC 2010). There is no literature on 
the use of tampons in Kenya. however, a study in the 
United states found that tampon users were more likely 
to choose the contraceptive vaginal ring than combined 
oral contraceptive pills.
Postpartum Family Planning
The level of family planning in the postpartum period 
remains low in the country with only 25% of postpartum 
women using a family planning method compared to 
the national CPR of 46% (KNBs and ICf Macro 2010; 
Gebreselassie, Rutstein, and Mishra 2008). In addi-
tion, the level of unmet need for family planning is 
more than twice as high among postpartum women 
(68%) compared to those in the general population 
(26%) (KNBs and ICf Macro 2010; Gebreselassie, 
Rutstein, and Mishra 2008). The postpartum period is 
also characterized by a limited range of available family 
planning methods that include LAM, IUCD, sterilization, 
progestin-only pills, injectables, and condoms, with 
injectables being the dominant contraceptive method 
used (Gebreselassie, Rutstein, and Mishra 2008).. The 
Ministry of Health therefore recognizes the need for 
family planning information and services during the 
postpartum period as an integral component of mater-
nal and neonatal care services (DRh/MOPhs 2010). 
however, programs to strengthen family planning 
service provision during the postpartum period have 
to date been donor-driven and implemented on a pilot 
basis in selected districts (Mwangi et al. 2008; Chebet 
and Jahonga 2011). These programs have, however, 
demonstrated substantial improvements in the uptake 
of family planning in the postpartum period (Mwangi et 
al. 2008; Chebet and Jahonga 2011).
figURe 2: tRends in Use of sPecific 
family Planning metHods
7BREASTFEEDING POLICIES 
AND PRACTICES
with respect to breastfeeding practices, nearly all chil-
dren under five years of age (97%) are ever breastfed. 
In addition, mothers initiate breastfeeding within one 
hour of birth for 58% and within one day of birth for 
86% of the children ever breastfed. forty-two percent 
of the children are given something other than breast 
milk (pre-lacteal liquids) during the first three days of 
life. The most commonly given pre-lacteal liquids in-
clude plain water (37%), sugar or glucose water (27%), 
sugar and salt water (23%), and other milk (13%). 
Other pre-lacteal liquids include gripe water (5%), fruit 
juice (1%), infant formula (2%), and tea/infusions 
(3%). The median duration for any breastfeeding is 21 
months while the median duration for exclusive breast-
feeding is less than one month. The median duration 
of breastfeeding is longer in rural than in urban areas 
(21 and 19 months, respectively) and in North Eastern 
compared to Nairobi province (26 and 15 months, re-
spectively). Ninety-three percent of children under the 
age of six months are breastfed six times or more in a 
24-hour period.
Only 32% of children under six months of age are ex-
clusively breastfed. This proportion is highest (52%) for 
children aged 0–1 month; after 8 months, the propor-
tion of children being exclusively breastfed declines to 
less than 1%. Therefore, there is a strong case for the 
progesterone vaginal ring since exclusive breastfeeding 
is not highly practiced and the hormones in the PVR 
are natural and therefore will not affect breastfeeding. 
however, in september 2012, parliament passed a 
law aimed at promoting exclusive breastfeeding for the 
first six months and continuous breastfeeding after the 
introduction of other foods up to a period of 24 months. 
The law has, however, been criticized for seeking to 
regulate the marketing, promotion, distribution, and 
sale of breast milk substitutes rather than promote 
exclusive breastfeeding (Maina 2012). The government 
has also formulated several policies aimed at protect-
ing, promoting and supporting optimal infant feeding 
practices (Republic of Kenya/MOPhs 2012).
SECURING CONTRACEPTIVE 
COMMODITIES AND GET-
TING THEM TO MARKET
for many years, the commodities and drug procure-
ment system in Kenya was based on the “push sys-
tem,” or one that anticipates future needs and fur-
nishes products in advance of those needs. however, in 
the past two years, Kenya has been experimenting with 
the “pull system,” or one that supplies orders that have 
already been filled. By November 2011, four provinces 
were piloting the “pull system” while the other four 
continued to use the “push system.” 
The current strategic plan (2011–2015) for the 
Division of Reproductive health addresses three main 
priority areas: demand creation, family planning com-
modity security, and adolescent health. There exists a 
strategic plan on reproductive health and family plan-
ning commodities that emphasizes:
• Regular updating of the commodity procurement 
plan reflecting Kenya government and donor commit-
ment;
• Timely procurement to ensure a full product pipeline;
• Improvement in technical capacity for forecasting 
and quantification at the district level; and
• Improvement in district oversight of the supply chain 
and the commodity information system. 
The Pharmacy and Poisons Board of Kenya is re-
sponsible for the overall regulation of new drugs and 
medical devices in Kenya. The board has published a 
number of guidelines to regulate clinical trials in Kenya 
	  
Breastfeeding in Kenya 
Children ever breastfed: 97% 
Median duration for any breastfeeding: 21 months 
Median duration for exclusive breastfeeding: < 1 
month 
8as well as on the submission of documentation for 
registration of medical devices and drugs. The Board is 
also responsible for approving the importation of limited 
quantities of drugs, including the PVR, into Kenya for 
the purpose of carrying out research activities.
Service Delivery
stakeholders in Kenya were consulted to identify where 
and how they thought the PVR would be most success-
fully integrated into the health system. All stakehold-
ers agreed that there should be no parallel systems 
and that the PVR should be distributed through either 
the private or public sector. Most participants favored 
introduction of the PVR through the public sector (6 
out of 10). A few stakeholders voiced preference for 
introduction through the private sector (3 out of 10), 
and one stakeholder suggested that the nongovernmen-
tal organization (NGO) sector would be a good channel. 
Kenya’s policy environment with regard to reproductive 
health and family planning is supportive of the introduc-
tion of new contraceptives regardless of the channel of 
distribution. 
STAKEHOLDER TYPE   NAME OF INSTITUTION
Government agencies & policymakers Ministry of Public health and sanitation-Division of Repro-
ductive health
Regulatory & quality assurance agencies Pharmacy & Poisons Board
Private-sector providers (family planning/ 
postpartum care)
Organization for Health, Education and Research Services 
(OHERS)- Non-governmental organization
Public/private partnership for health provider (in-
cluding  family planning/postpartum care)
Kenya Urban Reproductive health Initiative (KURhI-Jipange, 
Jhpiego)
Other organizations providing family planning/post-
partum care
Marie stopes, IPPf
Development agencies UsAID, whO, UNfPA, Kfw
social marketing Population services International (PsI)
Community representative & advocacy groups Maendeleo ya Wanawake Organization (MYWO)
Professional associations Kenya Obstetrical and Gynaecologcal society (KOGs) (fIGO-
Affiliate)
Research institutions fhI 360
Drug manufacturers/distributors Bayer East-Africa
NOTEs:  IPPf: International Planned Parenthood federation; UsAID: United states Agency for International Development; whO: world health 
Organization; UNFPA: United Nations  Population Fund; KfW:  Kreditanstalt für Wiederaufbau (German Development Bank); FIGO: International 
federation of Gynecology and Obstetrics.
table 3: staKeHoldeRs consUlted dURing coUntRy maPPing
9SUPPORT FOR THE PVR
The consensus arising from the stakeholder consulta-
tions was that the PVR is seen as an important addition 
to the family planning method mix for postpartum wom-
en. stakeholders would like to learn more about pricing 
and potential positioning of the product. They also had 
concerns about whether the product has been regis-
tered by the Us food and Drug Administration (which it 
has not due to the fact that breastfeeding is not as uni-
versal or prolonged). Other logistical and practical con-
siderations were also discussed to determine areas that 
should be addressed for successful introduction of the 
product. Most emphasized learning from the experience 
of sino-Implant, particularly with respect to the country 
where the product is manufactured, which is critical in 
influencing people’s perception. In addition, recommen-
dations were made to plan for advocacy activities and 
enlist female gynecologists as advocates to talk about 
the product in various forums and with women’s group 
leaders. stakeholders also advocated getting the PVR 
on the World Health Organization’s Essential Commodi-
ties list. The potential support for the PVR among users, 
partners, providers, and community members will be 
determined through acceptability studies.
DISCUSSION
After consideration of how family planning is perceived 
in Kenya’s socio-cultural and political environment and 
an analysis of the health system infrastructure, it ap-
pears that the introduction of the PVR would fill a gap 
in the family planning needs of breastfeeding women in 
Kenya. The strong support for future introduction of the 
PVR and the more immediate acceptability studies the 
Council is conducting as part of pre-introductory efforts 
further underscore the potential for the PVR to fill this 
gap. There is a need for contraceptives that require little 
training on the part of the provider, do not require a 
sophisticated health infrastructure; are long-acting and 
thus do not require monthly visits to a health center, 
and are user-friendly, woman-controlled, and safe. The 
PVR addresses all of these concerns and based on the 
information documented thus far, is likely to be a wel-
come addition to the existing contraceptive method mix. 
STAKEHOLDER RECOMMENDATIONS FOR 
INTRODUCTION
Find an advocate1. 
Develop a dossier of safety and efficacy 2. 
evidence to help fast-track registration
Avoid simultaneous introduction into mul-3. 
tiple sectors (public and private) 
Address any myths and misconceptions4. 
State benefits to woman, child and part-5. 
ner
Focus on the PVR’s ease of use6. 
Emphasize pharmacist training if product 7. 
is to be available over the counter
Address question of product pricing8. 
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DATE ORGANIzATION PERSON(S) SEEN
02.05.2012 Marie stopes International Dr. Edwin Mbugua
louise Patterson
Dr. Mark Ayallo
Gabrille Appleford
Dr. Cleophas Ondieki
04.05.2012 UsAID sheila Macharia
Emily Iruguthu
Division of Reproductive health (DRh) Dr. shiphrah Kuria
Dr. Agnes Nakato
Dr. Pamela Godia
Dr. Gathari Ndirangu
John Mwang
Damaris Mwanzia
Anne Njeru
11.05.2012 fhI 360 Dr. Marsden solomon
14.05.2012 Bayer East Africa Dr. Bernard Matheka
Mr. Bernard Mutua
Mr. Kuto
14.05.2012 Kfw Julia fimpel
15.05.2012 KURhI-JIPANGE/Jhpiego Mr. Nelson Keyonzo
Dr. Janet Omyonga
15.05.2012 PsI Anthony Okoth
Joyce Maina-wanderi
susan Karimi
16.05.2012 World Health Organization (WHO) Dr. Joyce lavussa
21.05.2012 Kenya Obstetrics and Gynecological society (KOGs) Dr. Guyo Jaldesa
21.05.2012 Organization for Health, Education and Research Services  
(OhERs)
Mrs. Nelly luchemo
Maureen
21.05.2012 Maendeleo Ya Wanawake Organization (MYWO) susan Atieno Chege
22.05.2012 The International Planned Parenthood federation Dr. lawrence Oteba
25.05.2012 UNfPA Dr. stephen wanyee
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